Survival statistics for penile cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.
There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for penile cancer and what they mean to you.
Relative survival looks at how likely people with cancer are to survive after their diagnosis compared to people in the general population who do not have cancer, but who share similar characteristics (such as age and sex).
In Canada, a 5-year relative survival statistic is reported for penile cancer. The 5-year relative survival for penile cancer is 67%. This means that, on average, men diagnosed with penile cancer are 67% as likely to live at least 5 years after their diagnosis as people in the general population.
Survival varies with each stage of penile cancer. The following factors can also affect survival for penile cancer.
There are no specific Canadian statistics available for the different stages of penile cancer. The following information comes from a variety of sources and may include statistics from other countries.
|Location of Tumour||5-year relative survival|
Penile cancer that is contained within the penis (stages 0–II)
Penile cancer that has spread to nearby tissues or lymph nodes* (stage III and some stage IV)
Penile cancer that has spread to distant sites in the body (some stage IV)
*The number of lymph nodes and the group of lymph nodes the cancer has spread to also play a role in predicting survival. Men who have cancer in only one lymph node in the groin (inguinal lymph node) have an 80% chance of being alive at least 5 years after their diagnosis. Men who have cancer in more than 2 inguinal lymph nodes or in another group of lymph nodes have a 40% chance of being alive at least 5 years after their diagnosis.
The 5-year survival rate refers to the percentage of people who are alive at least 5 years after their cancer diagnosis. However, people may live much longer than 5 years.
People with cancer should talk to their doctor about their prognosis. Prognosis depends on many factors, including:
Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis
A clinical trial led by the Society’s NCIC Clinical Trials group found that men with prostate cancer who are treated with intermittent courses of hormone therapy live as long as those receiving continuous therapy.